University of Ottawa
$25,000.00 CAD
≈ 4 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2018-2019
- Agreement period
- March 15, 2019 – March 31, 2020
- Reference
- nrc-cnrc:172-2018-2019-Q4-00044
Published purpose
Accumulation of toxic forms of alpha-synuclein plays a central role in the development of Parkinson's disease. We aim to harness the ability of cells' own nanovesicles to cross the blood-brain barrier, silence alpha-synuclein and protect nerve cells, paving the way for novel therapeutics for silencing key toxic genes in other neurodegenerative diseases
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions